Takagi, M., Ogawa, C., Iehara, T., Aoki‐Nogami, Y., Ishibashi, E., Imai, M., Kimura, T., Nagata, M., Yasuhara, M., Masutani, M., Yoshimura, K., Tomizawa, D., Ogawa, A., Yonemori, K., Morishita, A., Miyamoto, S., Takita, J., Kihara, T., Nobori, K., Hasebe, K., Miya, F., Ikeda, S., Shioda, Y., Matsumoto, K., Fujimura, J., Mizutani, S., Morio, T., Hosoi, H., & Koike, R. (2022). first phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors. Cancer, 128(15), 2949–2957. http://access.bl.uk/ark:/81055/vdc_100159171169.0x00005d